diethylcarbamazine
FDA Approved (limited availability)
Description
Diethylcarbamazine is an anthelmintic drug that acts against filarial parasites by altering the surface properties of microfilariae, making them more susceptible to host immune responses. It is particularly effective against Dirofilaria species and other filarial infections. The drug has been used for decades in the treatment of lymphatic filariasis and related parasitic conditions.
Indications & Therapeutic Use
Lymphatic filariasis, tropical pulmonary eosinophilia, loiasis, dirofilariasis
Linked Diseases:
dirofilariasis
D004184
Global Availability (7 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
diethylcarbamazine
| Generic Name | diethylcarbamazine |
| Brands | 1 brand available |
| Active Ingredient | diethylcarbamazine citrate |
| Drug Class | Lymphatic filariasis |
| Manufacturer | Various generic manufacturers |
| Dosage Forms | Oral tablet 50mg, 100mg |
| Medical Code | P02CB02 |
| Orphan Status | No |
| Cold Chain | Not Required |
| Lead Time | 7 days |
| Reg. Status | FDA Approved (limited availability) |
| Countries | 7 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations8 Validated Nodes